Literature DB >> 15965221

Gluten sensitivity and neuromyelitis optica: two case reports.

S Jacob1, M Zarei, A Kenton, H Allroggen.   

Abstract

Neuromyelitis optica is a clinical syndrome characterised by acute transverse myelitis plus an acute or subacute optic neuritis with or without recovery. Although once believed to be a variant of multiple sclerosis, diagnostic criteria have recently been proposed for neuromyelitis optica, making it a clinically distinct syndrome. The term gluten sensitivity refers to a state of heightened immunological responsiveness to ingested gluten in genetically susceptible individuals, as indicated by circulating antibodies to gliadin. Several neurological complications have been described associated with gluten sensitivity ranging from peripheral neuropathy and cerebellar ataxia to an increased risk of epilepsy. Although myelopathy has been described in some case reports of coeliac disease, neuromyelitis optica has never been described in association with gluten sensitivity. We describe two cases of gluten sensitivity presenting as neuromyelitis optica with no previous history of significant gastrointestinal symptoms. Gluten sensitivity was confirmed by immunological and histological studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965221      PMCID: PMC1739712          DOI: 10.1136/jnnp.2004.055491

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging.

Authors:  Patricia H McNamara; Lisa Costelloe; Yvonne Langan; Janice Redmond
Journal:  J Neurol       Date:  2010-11-05       Impact factor: 4.849

Review 2.  Ocular manifestations in celiac disease: an overview.

Authors:  Fotios S Fousekis; Andreas Katsanos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

Review 3.  Neuromyelitis optica spectrum disorders.

Authors:  Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

4.  Two cases of benign neuromyelitis optica in patients with celiac disease.

Authors:  R Bergamaschi; S Jarius; M Robotti; A Pichiecchio; B Wildemann; G Meola
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

Review 5.  Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.

Authors:  Altijana Hromić-Jahjefendić; Debmalya Barh; Cecília Horta Ramalho Pinto; Lucas Gabriel Rodrigues Gomes; Jéssica Lígia Picanço Machado; Oladapo Olawale Afolabi; Sandeep Tiwari; Alaa A A Aljabali; Murtaza M Tambuwala; Ángel Serrano-Aroca; Elrashdy M Redwan; Vladimir N Uversky; Kenneth Lundstrom
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

Review 6.  Thromboembolic complications and cardiovascular events associated with celiac disease.

Authors:  Fotios S Fousekis; Eleni T Beka; Ioannis V Mitselos; Haralampos Milionis; Dimitrios K Christodoulou
Journal:  Ir J Med Sci       Date:  2020-07-20       Impact factor: 1.568

7.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

8.  The onset of enhanced intestinal permeability and food sensitivity triggered by medication used in dental procedures: a case report.

Authors:  Aristo Vojdani; Jama Lambert
Journal:  Case Rep Gastrointest Med       Date:  2012-09-12

9.  A case of multiple sclerosis and celiac disease.

Authors:  H Z Batur-Caglayan; C Irkec; I Yildirim-Capraz; N Atalay-Akyurek; S Dumlu
Journal:  Case Rep Neurol Med       Date:  2013-01-13

Review 10.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.